ZYFLO Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Zyflo, and what generic alternatives are available?
Zyflo is a drug marketed by Chiesi and is included in two NDAs.
The generic ingredient in ZYFLO is zileuton. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the zileuton profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Zyflo
A generic version of ZYFLO was approved as zileuton by RISING on March 17th, 2017.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ZYFLO?
- What are the global sales for ZYFLO?
- What is Average Wholesale Price for ZYFLO?
Summary for ZYFLO
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 130 |
| Drug Prices: | Drug price information for ZYFLO |
| What excipients (inactive ingredients) are in ZYFLO? | ZYFLO excipients list |
| DailyMed Link: | ZYFLO at DailyMed |
Pharmacology for ZYFLO
| Drug Class | 5-Lipoxygenase Inhibitor |
| Mechanism of Action | 5-Lipoxygenase Inhibitors |
| Physiological Effect | Decreased Leukotriene Production |
US Patents and Regulatory Information for ZYFLO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chiesi | ZYFLO | zileuton | TABLET;ORAL | 020471-001 | Dec 9, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Chiesi | ZYFLO | zileuton | TABLET;ORAL | 020471-003 | Dec 9, 1996 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Chiesi | ZYFLO CR | zileuton | TABLET, EXTENDED RELEASE;ORAL | 022052-001 | May 30, 2007 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ZYFLO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Chiesi | ZYFLO | zileuton | TABLET;ORAL | 020471-001 | Dec 9, 1996 | ⤷ Sign Up | ⤷ Sign Up |
| Chiesi | ZYFLO | zileuton | TABLET;ORAL | 020471-003 | Dec 9, 1996 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ZYFLO
See the table below for patents covering ZYFLO around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Japan | H0569822 | ⤷ Sign Up | |
| Japan | H03148272 | LIPOXYGENASE CONTROL COMPOUND | ⤷ Sign Up |
| Japan | 2923014 | ⤷ Sign Up | |
| European Patent Office | 0416609 | Composés inhibiteurs de lipoxygénase dérivés du benzo[b]thiophène (Benzo[b]thiophene-containing lipoxygenase-inhibiting compounds) | ⤷ Sign Up |
| Australia | 6220190 | ⤷ Sign Up | |
| Japan | S63264456 | INDOLE, BENZOFURAN AND BENZOTHIOPHENE-CONTAINING LIPOXYGENASE INHIBITIVE COMPOUND | ⤷ Sign Up |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
